Concepedia
Statistics
Publications
64
Citations
14.7K
H-Index
41
Active since
1989
Affiliations
University of California, San Francisco(Current)
The University of Texas MD Anderson Cancer Center
The University of Texas Southwestern Medical Center
Dana-Farber Cancer Institute
University of Michigan
Karen Fink is an author at University of California, San Francisco specializing in medicine, oncology, and neuro-oncology.
Publications per year
1989–2022
Effect of Tumor-Treating Fields Plus Maintenance Temozolomide vs Maintenance Temozolomide Alone on Survival in Patients With Glioblastoma
Roger Stupp, Sophie Taillibert, Andrew A. Kanner et al. · JAMA · 2017 · 2.6K citations · Full text
Medicine, Neurosurgery, Oncology +16
Maintenance Therapy With Tumor-Treating Fields Plus Temozolomide vs Temozolomide Alone for Glioblastoma
Roger Stupp, Sophie Taillibert, Andrew A. Kanner et al. · JAMA · 2015 · 1.2K citations · Full text
Medicine, Oncology, Radiation Oncology +15
Phase III Trial of Chemoradiotherapy for Anaplastic Oligodendroglioma: Long-Term Results of RTOG 9402
Gregory Cairncross, Meihua Wang, Edward Shaw et al. · Journal of Clinical Oncology · 2012 · 1.2K citations · Full text
Medicine, Oncology, Radiation Oncology +14
Rindopepimut with temozolomide for patients with newly diagnosed, EGFRvIII-expressing glioblastoma (ACT IV): a randomised, double-blind, international phase 3 trial
Michael Weller, Nicholas Butowski, David Tran et al. · The Lancet Oncology · 2017 · 1.1K citations
Medicine, Oncology, Pharmacology +13
A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapse
W.K. Alfred Yung, Robert E. Albright, Jeffrey J. Olson et al. · British Journal of Cancer · 2000 · 939 citations · Full text
Medicine, Oncology, Pharmacology +17
1–5 of 64